CREB regulates MHC class II expression in a CIITA-dependent manner

Immunity

Volumn 10, Issue 2, 1999, Pages 143-151

  Moreno, Carlos S ^a,b   Beresford, Guy W ^a   Louis Plence, Pascale ^a,b   Morris, Ann C ^a   Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; DNA BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0033083701     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80015-1     Document Type: Article

References (66)

1. Andersson, G., and Peterlin, B. (1990). NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun. J. Immunol. 145, 3456-3462.
2. Barton, K., Muthusamy, N., Chanyangam, M., Fischer, C., Clendenin, C., and Leiden, J.M. (1996). Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 379, 81-85.
3. Basta, P.V., Sherman, P.A., and Ting, J.P. (1987). Identification of an interferon-gamma response region 5′ of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines. J. Immunol. 138, 1275-1280.
4. Benichou, B., and Strominger, J.L. (1991). Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88, 4285-4288.
5. Benoist, C., and Mathis, D. (1990). Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8, 681-715.
6. Blendy, J.A., Kaestner, K.H., Schmid, W., Gass, P., and Schutz, G. (1996). Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform. EMBO J. 15, 1098-1106.
7. Bodor, J., Spetz, A.L., Strominger, J.L., and Habener, J.F. (1996). cAMP inducibility of transcriptional represser ICER in developing and mature human T lymphocytes. Proc. Natl. Acad. Sci. USA 93, 3536-3541.
8. Boss, J.M. (1997). Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9, 107-113.
9. Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G., and Silva, A.J. (1994). Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79, 59-68.
10. Brown, J.A., Rogers, E.M.,and Boss, J.M. (1998). Mutational analysis of the MHC class II transactivator (CIITA) indicates a functional requirement for conserved LCD motifs and for interactions with the conserved W-box promoter element. Nucleic Acids Res. 26, 4128-4136.
11. Chrivia, J.C., Kwok, R.P.S., Lamb, N., Hagiwara, M., Montminy, M.R., and Goodman, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859.
12. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., and Strober, W. (1991). Current Protocols in Immunology, Volume 1 (New York: John Wiley and Sons).
13. Collins, T., Korman, A.J., Wake, C.T., Boss, J.M., Kappes, D.J., Fiers, W., Ault, K.A., Gimbrone, M.A., Jr., Strominger, J.L., and Pober, J.S. (1984). Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81, 4917-4921.
14. Dedon, P.C., Soults, J.A., Allis, C.D., and Gorovsky, M.A. (1991a). A simplified formaldehyde fixation and immunoprecipitation technique for studying protein-DNA interactions. Anal. Biochem. 197, 83-90.
15. Dedon, P.C., Soults, J.A., Allis, C.D., and Gorovsky, M.A. (1991b). Formaldehyde cross-linking and immunoprecipitation demonstrate developmental changes in H1 association with transcriptionally active genes. Mol. Cell Biol. 11, 1729-1733.
16. Dey, A., Thornton, A.M., Lonergan, M., Weissman, S.M., ChamberLain, J.W., and Ozato, K. (1992). Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol. Cell. Biol. 12, 3590-3599.
17. Durand, B., Sperisen, P., Emery, P., Barras, E., Zufferey, M., Mach, B., and Reith, W. (1997). RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency. EMBO J. 16, 1045-1055.
18. Emery, P., Durand, B., Mach, B., and Reith, W. (1996). RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res. 24, 803-307.
19. Fontes, J.D., Kanazawa, S., Jean, D., and Peterlin, B.M. (1999). Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19, 941-947.
20. Glimcher, L.H., and Kara, C.J. (1992). Sequences and factors: A guide to MHC class II transcription. In Annual Reviews of Immunology, W.E. Paul, C. Garrison Fathman, and H. Metzger, eds. (Palo Alto: Annual Reviews Inc.), pp. 13-50.
21. Gobin, S.J.P., Peijnenburg, A., Keijsers, V., and van den Elsen, P.J. (1997). Site α is crucial for two routes of IFNγ-induced MHC class I transactivation: The ISRE-mediate route and a novel pathway involving CIITA. Immunity 6, 601-611.
22. 2-microglobulin genes. Immunity 9, 531-541.
23. Gonzalez, G.A., and Montminy, M.R. (1989). Cyclic AMP stimulates somatostatin gene transcription by phophorylation of CREB at serine 133. Cell 59, 675-680.
24. Hardingham, G.E., Chawla, S., Johnson, C.M., and Bading, H. (1997). Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385, 260-265.
25. Hasegawa, S.L., and Boss, J.M. (1991). Two distinct B cell factors bind the HLA-DRA X box region and recognize different subsets of MHC class II promoters. Nucleic Acids Res. 19, 6269-6276.
26. Hasegawa, S.L., Sloan, J.H., Reith, W., Mach, B., and Boss, J.M. (1991). Regulatory factor-X binding to mutant HLA-DRA promoter sequences. Nucleic Acids Res. 19, 1243-1249.
27. Hasegawa, S.L., Riley, J.L., Sloan, J.H., and Boss, J.M. (1993). Protease treatment of nuclear extracts distinguishes between class II major histocompatibility complex X1 box DNA-binding proteins in wild type and class II deficient B cells. J. Immunol. 150,1781-1793.
28. Ivashkiv, L.B., and Glimcher, L.H. (1991). Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements. J. Exp. Med. 174, 1583-159
29. Ivashkiv, L.B., Liou, H.C., Kara, C.J., Lamph, W.W., Verma, I.M., and Glimcher, L.H. (1990). mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-0-tetradecanoylphorbol-13-acetate, response element. Mol. Cell Biol. 10, 1609- 1621.
30. Kretsovali, A., Agaloti, T., Spilianakis, C., Tzortzakaki, E., Merika, M., and Paparnatheakis, J. (1998). Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18, 6777-6783.
31. Kuo, M.-H., Zhou, J., Jambeck, P., Churchill, M.E.A., and Allis, C.D. (1998). Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes Dev. 12, 627-639.
32. Kushida, M.M., Dey, A., Zhang, X.L., Campbell, J., Heeney, M., CarLyle, H., Ganguly, S., Ozato, K., Vasavada, H., and Chamberlain, J.W. (1997). A 150-base pair 5′ region of the MHC class I HLA-B7 gene is sufficient to direct tissue-specific expression and locus control region activity: The alpha site determines efficient expression and in vivo occupancy at multiple cis-active sites throughout the region. J. Immunol. 159, 4913-4929.
33. Kwok, R.P.S., Lundblad, J.R., Chrivia, J.C., Richards, J.P., BachinGer, H.P., Brennan, R.G., Roberts, S.G.E., Green, M.R., and GoodMan, R.H. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226.
34. Laoide, B.M., Foulkes, N.S., Schlotter, F., and Sassone-Corsi, P. (1993). The functional versatility of CREM is determined by its modular structure. EMBO J. 12, 1179-1191.
35. Liou, H.C., Boothby, M.R., Finn, P.W., Davidon, R., Nabavi, N., ZelezNik-Le, N.J., Ting, J.P.-Y., and Glimcher, L.H. (1990). A new member of the leucine zipper class of proteins that binds to the HLA DRa promoter. Science 247, 1581-1584.
36. Louis-Plence, P., Moreno, C.S., and Boss, J.M. (1997b). Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159, 3899-3909.
37. Mach, B., Steimle, V., Martinez-Soria, E.,and Reith, W. (1996). Regulation of MHC class II genes: Lessons from a disease. Annu. Rev. Immunol. 14, 301-331.
38. Martin, B.K., Chin, K.-C., Olsen, J.C., Skinner, C.A., Dey, A., Ozato, K., and Ting, J.P.-Y. (1997). Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6, 581-600.
39. Masson, N., Ellis, M., Goodbourn, S., and Lee, K.A.W. (1992). Cyclic AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter. Mol. Cell. Biol. 12, 1096-1106.
40. Mayall, T.P., Sheridan, P.L., Montminy, M.R., and Jones, K.A. (1997). Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev. 11, 887-899.
41. Molina, C.A., Foulkes, N.S., Lalli, E., and Sassone-Corsi, P. (1993). Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response represser. Cell 75, 875-886.
42. Montminy, M.R., and Bilezikjian, L.M. (1987). Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328, 175-178.
43. Moreno, C.S., Emery, P., West, J.E., Durand, B., Reith, W., Mach, B., and Boss, J.M. (1995). Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155, 4313-4321.
44. Moreno, C.S., Rogers, E.M., Brown, J.A., and Boss, J.M. (1997). RFX, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J. Immunol. 158, 5841-5848.
45. Nagarajan, U., Louis-Plence, P., Desandro, A., Nilsen, R., Bushey, A., and Boss, J.M. (1999). RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10, 153-16
46. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and NakaTani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
47. Ono, S.J., Bazil, V., Levi, B-Z., Ozato, K., and Strominger, J.L. (1991a). Transcription of a subset of human class II major histocompatibility complex genes is regulated by a nucleoprotein complex that contains c-fos or an antigenically related protein. Proc. Natl. Acad. Sci. USA 88, 4304-4308.
48. Ono, S.J., Liou, H.C., Davidson, R., Strominger, J.L., and Glimcher, L.H. (1991b). Human X-box binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc. Natl. Acad. Sci. USA 88, 4309-4312.
49. Riley, J.L., Westerheide, S.D., Price, J.A., Brown, J.A., and Boss, J.M. (1995). Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2, 533-543.
50. Roper, R.L., Ludlow, J.W., and Phipps, R.P. (1994). Prostaglandin E2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins. Cell. Immunol. 154, 296-308.
51. Scholl, T., Mahanta, S.K., and Strominger, J.L. (1997). Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94, 6330-6334.
52. Seidl, C., Saraiya, C., Osterweil, Z., Fu, Y.P., and Lee, J.S. (1992). Genetic complexity of regulatory mutants defective for HLA class II expression. J. Immunol. 148, 1576-1584.
53. Short, M.L., Manohar, C.F., Furtado, M.R., Ghadge, G.D., Wolinsky, S.M., Thimmapaya, B., and Jungmann, R.A. (1991). Nucleotide and derived amino-acid sequences of the CRE-binding proteins from rat C6 glioma and Hela cells. Nucleic Acids Res. 19, 1096-1106.
54. Sloan, J.H., Hasegawa, S.L., and Boss, J.M. (1992). Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J. Immunol. 148, 2591-259
55. Steimle, V., Otten, L.A., Zufferey, M., and Mach, B. (1993). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (bare lymphocyte syndrome). Cell 75, 135-146.
56. Steimle, V., Durand, B., Emmanuele, B., Zufferey, M., Hadam, M.R., Mach, B., and Reith, W. (1995). A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9, 1021-1032.
57. Tinti, C., Conti, B., Cubells, J.F., Kim, K.S., Baker, H., and Joh, T.H. (1996). Inducible cAMP early repressor can modulate tyrosine hydroxylase gene expression after stimulation of cAMP synthesis. J. Biol. Chem. 271, 25375-25381.
58. Unanue, E.R., Harding, C.V., Luescher, I.F., and Roof, R.W. (1989). Antigen-binding function of class II MHC molecules. Cold Spring Harbor Symp. Quant. Biol. 54, 383-392.
59. Wallon, K.M., Rehfuss, R.P., Chrivia, J.C., Lochner, J.E., and GoodMan, R.H. (1992). A dominant repressor of cyclic adenosine 3′,5′-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo. Mol. Endocrinol. 6, 647-655.
60. Westerheide, S.D., Louis-Plence, P., Ping, D., He, X.-F., and Boss, J.M. (1997). HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J. Immunol. 158, 4812-482
61. Wright, K.L., Chin, K.-C., Linhoff, M., Skinner, C., Li, G., Boss, J.M., Stark, G.R., and Ting, J.P.-Y. (1998). CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA 95, 6267- 6272.
62. Xie, H., and Rothstein, T.L. (1995). Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in B lymphocytes stimulated through surface Ig. J. Immunol. 154, 1717-1723.
63. Xie, H., Wang, Z., and Rothstein, T.L. (1996). Signaling pathways for antigen receptor-mediated induction of transcription factor CREB in B lymphocytes. Cell. Immunol. 169, 264-270.
64. Yamamoto, K.K., Gonzalez, G.A., Biggs, W.H., III, and Montminy, M.R. (1988). Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334, 494-498.
65. Yamamoto, K.K., Gonzalez, G.A., Menzel, P., Rivier, J., and MontMiny, M.R. (1990). Characterization of a bipartite activator domain in transcription factor CREB. Cell 60, 611-617.
66. Zhou, H., and Glimcher, L.H. (1995). Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2, 545-553.